YuanYuanMD

Oncology • Duarte, CA

Breast Cancer

Assistant Professor/City of Hope Comprehensive Cancer Center

Join to view full profile

Dr. Yuan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Yuan's full profile

Already have an account?

Office
1500 East Duarte Rd
Duarte, CA 91010
Phone+1 626-471-9200
Is this information wrong?

Education & Training

Xuzhou Medical CollegeClass of 1994
NYU Grossman School of MedicineResidency, Internal Medicine

Certifications & Licensure

CA State Medical License 2019 - 2025
LA State Medical License 2021 - 2022
NY State Medical License 2009 - 2012
American Board of Internal Medicine Medical Oncology

Clinical Trials

Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer Start of enrollment: 2008 Sep 04
Completed
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2010 May 17
Completed
Phase 1
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer Start of enrollment: 2012 Feb 15
Active, not recruiting
Phase 2
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer Start of enrollment: 2014 Oct 01
Completed
Phase 1
Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer Start of enrollment: 2016 Dec 02
Completed
Phase 2
Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer Start of enrollment: 2016 Sep 30
Recruiting
Phase 2
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer Start of enrollment: 2017 Jun 01
Completed
Phase 2
Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer Start of enrollment: 2019 Mar 04
Completed
Phase 1, Phase 2
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer Start of enrollment: 2023 Oct 13
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer Start of enrollment: 2021 Oct 18
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

9 citations
Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study.
Joanne E. Mortimer, James R. Bading, Paul Frankel, Mary Caroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Poku, John E. Shively, David Colcher> ;Journal of Nuclear Medicine. 2021 Dec 1
17 citations
Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study.
Bihong T. Chen, Ningrong Ye, Chi Wah Wong, Sunita K. Patel, Taihao Jin, Can Lan Sun, Russell C. Rockne, Heeyoung Kim, James C. Root, Andrew J. Saykin, Tim A. Ahles, An...> ;Journal of Geriatric Oncology. 2020 Mar 1
27 citations
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
Jin Sun Lee, Susan E. Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Holly Yin, Raju Pillai, Kim Robinson, Aileen Tang, Norma Martinez, Jana Portnow, Wei Wen, John ...> ;Breast Cancer Research. 2019 Nov 8
58 citations
Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts.
Katherine E. Hutchinson, Susan E. Yost, Ching-Wei Chang, Radia M. Johnson, Adrian R. Carr, Paul R. McAdam, Daniel L. Halligan, Chun-Chieh Chang, Daniel Schmolze, Jacks...> ;Clinical Cancer Research. 2020 Feb 1
16 citations
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.
Jasmine A. McQuerry, David Jenkins, Susan E. Yost, Yuqing Zhang, Daniel Schmolze, W. Evan Johnson, Yuan Yuan, Andrea Bild> ;BMC Cancer. 2019 Sep 5
18 citations
Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer
Yuan Yuan, Wei Wen, Susan E. Yost, Quanhua Xing, Jin Yan, Ernest S. Han, Joanne E. Mortimer, John H. Yim> ;Scientific Reports. 2019 May 17
40 citations
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
Zi-Ming Zhao, Susan E. Yost, Katherine E. Hutchinson, Sierra Min Li, Yate-Ching Yuan, Javad Noorbakhsh, Zheng Liu, Charles Warden, Radia M. Johnson, Xiwei Wu, Jeffrey ...> ;BMC Cancer. 2019 Jan 21
29 citations
Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
Yuan Chun Ding, Linda Steele, Charles Warden, Sharon P. Wilczynski, Joanne E. Mortimer, Yuan Yuan, Susan L. Neuhausen> ;Oncotarget. 2019 Jan 4
29 citations
Sentinel lymph node B cells can predict disease-free survival in breast cancer patients
Kim Blenman, Ting-Fang He, Paul Frankel, Nora H. Ruel, Erich J. Schwartz, David N. Krag, Lee K. Tan, John H. Yim, Joanne E. Mortimer, Yuan Yuan, Peter P. Lee> ;NPJ Breast Cancer. 2018 Aug 23
27 citations
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer
Yuan Yuan, Nilesh Vora, Can-Lan Sun, Daneng Li, Enrique Soto-Perez-de-Celis, Joanne E. Mortimer, Thehang H. Luu, G. Somlo, J Waisman, David D. Smith, Joseph Chao, Vani...> ;Breast Cancer Research. 2017 Aug 29
3 citations
Association of Pre‐Chemotherapy Peripheral Blood Pro‐Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer
Yuan Yuan, Nilesh Vora, Can-Lan Sun, Daneng Li, David D. Smith, Joanne E. Mortimer, Thehang Luu, George Somlo, James Waisman, Joseph Chao, Vani Katheria, Timothy W. Sy...> ;The Oncologist. 2017 Oct 1
Join now to see all

Hospital Affiliations

City of Hope Comprehensive Cancer CenterDuarte, California
Cedars-Sinai Medical CenterLos Angeles, California

YuanYuanMD

Dr. Yuan is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.